The study involving 2,499 Belgian health-care workers who were vaccinated with two doses of either company's vaccine was published on Monday in the Journal...
A study comparing individual immune responses to two major COVID-19 vaccines has shown that Moderna’s created more than double the antibodies than that of Pfizer and BioNTech.
The research showed that previously infected participants had higher antibody levels than those who had not been infected, but Moderna’s MRNA, +4.79% vaccine came out ahead for both groups. For those without previous infections, the antibody levels were 2881 units per milliliter among the Moderna candidates and 1108 for those who had the Pfizer PFE, -BioNTech BNTX, +1.76% vaccine.
Read: WHO warns of possible 236,000 new COVID-19 deaths in Europe by December, and Fauci says U.S. could see another 100,000
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
U.S. COVID-19 booster rollout to initially proceed with just Pfizer vaccine - sourceThe U.S government's plan to roll out additional shots of the COVID-19 vaccine for the general public on Sept. 20 will proceed with just the Pfizer /BioNTech SE vaccine, a source familiar with the discussion said on Friday.
Read more »
Fauci Foresees ‘Full Vaccination’ Including Booster ShotsThe phrase “fully vaccinated” will eventually change to mean a person has gotten a booster shot -- not just the initial doses of a COVID-19 vaccine, Dr. Anthony Fauci predicts.
Read more »
U.S. to deliver over 500K Pfizer COVID-19 vaccine doses to KosovoThe United States is set to deliver 503,100 doses of the Pfizer COVID-19 vaccine to the Republic of Kosovo this weekend. Vice President Kamala Harris delivered the news to Kosovo President Vjosa Osmani-Sadriu during a phone call Friday.
Read more »
Being fully vaccinated reduces odds of long Covid-19 by half, UK study suggestsA new study of breakthrough Covid-19 infections finds that vaccines not only reduce the risk of severe disease and hospitalization, but also can lower the odds of having long-term Covid-19 symptoms.
Read more »
U.S. COVID-19 booster shot campaign to start with only Pfizer - sourceWASHINGTON (Reuters) - A White House plan to offer COVID-19 booster shots will most likely start this month only with the vaccine made by Pfizer Inc and BioNTech, a narrower initiative than anticipated, a source familiar with the matter said on Friday.
Read more »